
This text was featured within the One Story to Learn Immediately e-newsletter. Sign up for it here.
Just a few years in the past, West Virginia, which has the very best weight problems fee within the nation, quietly started a small and strange pilot program that might contact tons of of lives: It began overlaying weight problems medicine for state staff—at the same time as many different insurers balked at what they thought-about costly “vanity” medicine.
This system was, by well being measures, a hit. Sufferers shed as a lot as 120 kilos, their ldl cholesterol dropped, their prediabetes light, and so they minimize down on blood-pressure meds. As phrase started to unfold, extra sufferers needed to affix. A college nurse instructed me her weight reduction impressed not less than six different lecturers and workers to get into the pilot program too.
Then all of it got here to an abrupt finish. In March, the state’s Public Worker Insurance coverage Company (PEIA) determined it may not bear the crushing prices of Wegovy and Zepbound. (These weight problems medicine are generally higher identified by the model names Ozempic and Mounjaro, respectively, which is how they’re offered for diabetes.) Within the months after, PEIA sufferers started operating out of treatment. They rationed their remaining provides, stretching the weekly injections to 10 days, two weeks, even three weeks. They thought-about copycat compounded versions. One girl started sharing her diabetic mom’s Ozempic. Those that may not get the medicine felt their “meals noise,” the fixed ideas about consuming that the weight problems medicine suppress, return with a vengeance. And so they have regained weight.
West Virginia’s pilot program is a microcosm of the dilemma posed by new weight problems medicine which can be without delay efficient and shockingly costly. Sufferers, medical doctors, and insurers alike are caught in an intractable scenario. Because the program ended, Laura Davisson, the director of medical weight administration at West Virginia College, instructed me, “there’s a variety of desperation that we’re seeing in our observe.” Her heart was certainly one of a handful within the state’s pilot program, which was at all times small; it enrolled about 1,000 sufferers at its peak, a tiny fraction of the greater than 200,000 West Virginians who depend on PEIA. (About two in 5 folks in West Virginia have weight problems.) And these 1,000 sufferers have since turn into unwitting topics in an experiment about what occurs when sufferers are given a life-changing drug—solely to have it taken away.

Megan Pigott is what one may name a Wegovy super-responder; she misplaced 120 kilos, greater than a 3rd of her physique weight, after beginning the drug in 2022. Earlier than that, she had been counting energy since elementary college; she had tried SlimFast shakes, a cabbage-and-green-pepper-soup eating regimen that left her depressing, and an older weight problems drug known as liraglutide. Nothing labored in addition to Wegovy, which WVU prescribed for her as a part of a weight-management plan that additionally included dieting and exercise. The drug is supposed to be taken indefinitely, first to assist sufferers shed weight after which to maintain it off. Wegovy, Pigott instructed me, lastly gave her hope.
After PEIA minimize off protection, she ran out of Wegovy in July. Half of the burden she misplaced has already come again. She is now contemplating a generic model of liraglutide, regardless of the drug inflicting vomiting and diarrhea when she beforehand took it. (Wegovy may cause these negative effects, too, however Pigott personally discovered them milder.) To afford even this cheaper and fewer efficient treatment, she plans to drive an hour and half to the closest Ceremony Support, which takes a coupon that reduces the price to $245 a month. Wegovy’s out-of-pocket value, which is greater than double that even with a producer’s coupon, is out of the query. “I felt like a drug seeker,” Pigott instructed me, going to such lengths for treatment to shed weight. She is prepared to attempt as a result of, like different PEIA sufferers I interviewed, she discovered that managing her weight problems had reversed a lot of what ailed her physique.
When Cassie Hornbeck Maxwell began Wegovy, she had already been identified with prediabetes, sleep apnea, and polycystic ovarian syndrome, a hormonal dysfunction that may trigger irregular durations—all of that are related to weight problems. “I had given up on myself,” she instructed me. “I had given up on my well being.” With Wegovy, her well being issues light away one after the other: Her blood sugar went down, she stopped needing a CPAP machine to sleep, and her durations grew to become common. Her expertise matches rising anecdotal and medical proof that weight problems medicine can mitigate these related situations.
Hilaria Eire Swisher has minimize her use of blood-pressure treatment in half. She instructed me she had cried when she first began on Zepbound, so overwhelmed was she to have—after a lifetime of weight-reduction plan, weight-reduction plan, weight-reduction plan, and regaining the burden anyway—a drug which may lastly finish her well being struggles. Weight problems made her on a regular basis life troublesome: She used to lose her breath climbing a flight of stairs, and her toes would ache for days after outlet purchasing with pals. However the drug-induced weight reduction kicked off a virtuous cycle. She will transfer with out ache, so she could be extra lively and hold more healthy habits. Now she goes to the health club twice every week.
This is the reason sufferers on PEIA don’t need to lose entry to the medicine. Regardless of the downsides of the medicine—the long-term side effects are still unknown—sufferers don’t need to return. The pilot program has been a little bit of a curler coaster for sufferers, says Bisher Mustafa, a weight-management specialist at Marshall Well being, one of many facilities within the PEIA pilot program. Davisson at WVU has been advocating for PEIA to maintain not less than the sufferers within the pilot program on the medicine. Kicking them off Wegovy and Zepbound now, she argues, would reverse the progress already made: “All that cash you simply put in, you’re going to throw away.”

Across the nation, nonetheless, different insurers confronted with the identical prices as PEIA have been largely unswayed by the argument that overlaying weight problems medicine will finally lower your expenses, by stopping obesity-related situations akin to diabetes and coronary heart assaults down the road. North Carolina additionally dropped protection for state staff earlier this year, and personal insurance coverage has been cutting patients off too. Wegovy and Zepbound are nonetheless new sufficient that agency proof of price financial savings is difficult to return by. A handful of studies and simulations, although, recommend that any future well being financial savings will nonetheless be dwarfed by the price of the medicine, not less than at present costs. A simulation from Wegovy’s producer, Novo Nordisk, for instance, discovered a financial savings of $85 million over 5 years for 100,000 sufferers—however the present record value of Wegovy over that very same interval would run $8 billion, an enormous discrepancy even when insurers don’t pay full value.
In West Virginia, PEIA says it was combating prices: The pilot program for 1,000 sufferers ran at roughly $15 million a yr at its peak. Increasing it to 10,000 sufferers would require $150 million a yr, or 40 % of the company’s complete prescription-drug price range. “I’ve laid awake at night time just about since I made the choice,” the company’s director, Brian Cunningham, said in June. “However I’ve a fiduciary accountability, and that’s my No. 1 accountability.” (PEIA didn’t reply to The Atlantic’s questions on ending the pilot program.) Shutting down the pilot program places West Virginia according to different states: Most by no means coated the weight problems medicine for state staff within the first place. Solely about a quarter of Americans, with any form of insurance coverage, have protection for these drugs, in keeping with Weight problems Protection Nexus.
For the West Virginians who briefly gained after which misplaced protection, this discuss of numbers can really feel slightly summary in contrast with the change they really feel so viscerally of their our bodies every single day. To insurers, a coronary heart assault averted could be a quantity in a spreadsheet, however to sufferers, that is their life. Some have written letters to PEIA and state legislators pleading their case. Angela Younger, a retired state worker (who wasn’t a part of the pilot however misplaced protection when she acquired on PEIA after a divorce), put it to me most bluntly. She feels the additional weight within the knee she had changed. She struggles with shortness of breath and coronary heart issues. “I’m assuming,” she mentioned, “that is finally going to kill me.”

Even a brief stint on the weight problems medicine, PEIA sufferers instructed me, modified their lives in methods past the bodily. “Once you’re an obese particular person, it’s such as you’re invisible,” Lory Osborn mentioned. “Such as you’re lower than an individual,” Randi Bourne, the college nurse with six co-workers within the pilot program, instructed me. That they had at all times been conscious of the fat-shaming, the willful ignoring, the refined and not-so-subtle disrespect, however dropping pounds opened their eyes to simply how otherwise society handled folks with weight problems. Maxwell felt she had misplaced a part of her identification when she was seen first as “the fats particular person.” Losing a few pounds lastly let her be seen as herself—as Cassie—however would regaining it erase part of her identification once more?
The medicine additionally made Maxwell rethink how she thought of herself and about weight problems. Like many, she had lengthy thought-about weight problems an issue of self-discipline and motivation. Being on Wegovy after which Zepbound—feeling the meals noise disappear with a tweak in mind chemistry—made her see it as a medical situation. Weight problems is extra difficult than a easy imbalance of the hormone mimicked by these medicine, however medical doctors do now usually think about it a continual illness. Maxwell now sees it that method too.

To her, and different sufferers, that makes PEIA’s resolution all of the extra unjustifiable. “It’s the identical factor as giving somebody with most cancers a most cancers drug, or somebody with diabetes their insulin,” Swisher mentioned of the weight problems medicine. Placing them in a distinct class, many mentioned, felt like one more occasion of discrimination. Traditionally, the reluctance of insurance coverage corporations to cowl weight problems drugs is born out of a belief that obesity is a personal failing. Medicare remains to be prohibited by legislation from overlaying drugs for weight reduction; the Biden administration lately proposed a rule to sidestep that legislation, however the Trump administration would wish to approve it.
Within the fall, PEIA proposed raising premiums for next year. It even cited the high cost of GLP-1 drugs, the category that features Wegovy and Zepbound, as a key motive. However PEIA had already canceled the obesity-drugs pilot program. The price, going ahead, can be from funding the medicine prescribed for diabetes. (The pilot program was so small that some 86 % of the cash PEIA had been spending on GLP-1 medicine was nonetheless for diabetes therapy. Nonetheless, about two or 3 times extra folks in West Virginia have weight problems than diabetes, so increasing the pilot program would make weight problems prices a lot larger.) The company didn’t suggest eliminating protection for diabetes.
When Pigott began Wegovy, she was prediabetic. “One of many causes I took the drugs was to forestall myself from getting diabetes,” she mentioned. And it labored: Her blood-sugar ranges went down. Now her premiums are going up, and she nonetheless can’t get the drug—not except, after all, she finally does develop diabetes. “It doesn’t make sense,” she mentioned. To get assist, she would first should get sicker.
What have you ever skilled whereas taking GLP-1 medicine? Share your story with us.
(By writing to us, you might be agreeing to let The Atlantic use your response, which we might edit for size or readability. You’re additionally agreeing that The Atlantic’s reporters might contact you on the tackle supplied to debate whether or not you’ll be prepared to be interviewed.)
Source link